Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » Brisbane NET Patient Forum November 2022

Brisbane NET Patient Forum November 2022

  • November 1, 2022

After a long period of no face to face events due to COVID, NECA facilitated a NET Patient Education Forum, Tuesday 1 November 2022, at the Brisbane Convention Centre.

This was held from 5.30 – 7.30pm and had over 30 patients and carers attending. We were so grateful to have three NET Specialists from RBWH presenting – A/Prof David Pattison (Nuclear Medicine Physician / Endocrinologist), Dr Amanda Love (Endocrinologist) and Dr Mark Nalder (Medical Oncologist). Meredith Cummins (CEO) opened the event with current statistics on the incidence and prevalence of NETs and an overview of NECAs activities.

Topics discussed at the Forum were an overview of NETs including grading, staging, treatments and clinical trials by Dr Nalder, Hereditary NETs by Dr Love and delivery of PRR, PET scans, new frontiers of Nuclear Medicine treatments and Clinical Trials by  A/Prof Pattison. After the presentations there was time for patients to ask questions of the speakers. This was a very interactive part of the evening and was very much appreciated by all attending to have the opportunity to meet together, gain valuable information and meet some of the NET Specialists in Queensland.

We look forward to being able to hold more forums nationally.

Share this post

Recent posts

13th INCA Global NET Patient Advocate Summit

September 16, 2025

PCPA Cancer Summit

September 12, 2025

SCAN 2025 is now open – we need your voice

September 8, 2025

NeuroEndocrine Cancer Australia at PharmaAus2025

September 3, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPrevious2022 NET Cancer Day
NextCOSA Neuroendocrine Neoplasms (NENs) guidelines open for public consultationNext

Related Posts

13th INCA Global NET Patient Advocate Summit

This week our CEO Meredith Cummins, in her role as President Elect of the INCA Board of Directors and Chair of the Research Committee, presented at

PCPA Cancer Summit

  The Private Cancer Physicians of Australia (PCPA) hosted its Annual Meeting: Cancer Summit 2025 in Sydney on 13 September, bringing together clinicians, researchers, and

SCAN 2025 is now open – we need your voice

SCAN 2025 is now open – we need your voice.  As a proud member of the International Neuroendocrine Cancer Alliance (INCA), NeuroEndocrine Cancer Australia is excited

NeuroEndocrine Cancer Australia at PharmaAus2025

NeuroEndocrine Cancer Australia CEO Meredith Cummins and Media and External Relations Manager Ciara Connolly attended PharmaAus2025, one of Australia’s leading events for the pharmaceutical and

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin